Xiang X P, Zhou T, Li S L, Zhu X, Ding L M, Ma D M
Department of Clinical Laboratory, Third Affiliated Hospital, Beijing University of Chinese Medicine,Beijing 100029,China.
Zhonghua Yu Fang Yi Xue Za Zhi. 2024 Sep 6;58(9):1384-1387. doi: 10.3760/cma.j.cn112150-20240521-00411.
To study the clinical correlation between fasting plasma glucose, lipid metabolism, prostate-specific antigen and prostate volume in patients with benign prostatic hyperplasia, and to explore the combined effect as diagnostic indicators. A total of 108 patients with benign prostatic hyperplasia treated in Beijing University of Chinese Medicine Third Affiliated Hospital from June 2021 to March 2023 were retrospectively analyzed as the hyperplasia group, and 98 healthy physical examination personnel were selected as the control group during the same period. Compare the differences in levels of fasting plasma glucose (FPG), total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), small and dense low-density lipoprotein cholesterol (sdLDL-C), homocysteine, lipoprotein a (LPa), prostate specific antigen (PSA), and free prostate specific antigen (fPSA) between two groups of patients. Using Pearson analysis method to analyze the correlation between the above indicators and the size of prostate volume in patients with benign prostatic hyperplasia; using multiple linear regression to analyze the influencing factors of prostate volume enlargement; draw receiver operating characteristic (ROC) curves and analyze the application value of individual and combined detection of HDL, FPG, PSA, and fPSA. The results showed that there were significant differences in HDL, FPG, PSA, and fPSA levels between the control group and the proliferative group(<0.05). The size of prostate volume is negatively correlated with HDL(=-0.183, <0.05) and positively correlated with FPG (=0.202, <0.05), PSA(=0.412, <0.05), and fPSA(=0.425, <0.05). The results of multiple linear regression analysis showed that HDL(=0.000), FPG(=0.048), PSA(=0.044), and fPSA (=0.012) were risk factors for increased volume of benign prostatic hyperplasia; ROC curve analysis shows that the AUC of HDL, FPG, PSA, and fPSA combined detection is 0.823, which is better than individual detection. In conclusion,HDL, FPG, PSA, fPSA has close correlation with hyperplasia of prostate, the joint detection may has better prediction for benign prostatic hyperplasia.
研究良性前列腺增生患者空腹血糖、脂质代谢、前列腺特异性抗原与前列腺体积之间的临床相关性，并探讨联合检测作为诊断指标的作用。回顾性分析2021年6月至2023年3月在北京中医药大学第三附属医院接受治疗的108例良性前列腺增生患者作为增生组，同期选取98例健康体检人员作为对照组。比较两组患者空腹血糖（FPG）、总胆固醇（TC）、甘油三酯（TG）、高密度脂蛋白胆固醇（HDL-C）、低密度脂蛋白胆固醇（LDL-C）、小而密低密度脂蛋白胆固醇（sdLDL-C）、同型半胱氨酸、脂蛋白a（LPa）、前列腺特异性抗原（PSA）和游离前列腺特异性抗原（fPSA）水平的差异。采用Pearson分析法分析上述指标与良性前列腺增生患者前列腺体积大小的相关性；采用多元线性回归分析前列腺体积增大的影响因素；绘制受试者工作特征（ROC）曲线，分析HDL、FPG、PSA和fPSA单项及联合检测的应用价值。结果显示，对照组与增生组HDL、FPG、PSA和fPSA水平存在显著差异（<0.05）。前列腺体积大小与HDL呈负相关（=-0.183，<0.05），与FPG（=0.202，<0.05）、PSA（=0.412，<0.05）和fPSA（=0.425，<0.05）呈正相关。多元线性回归分析结果显示，HDL（=0.000）、FPG（=0.048）、PSA（=0.044）和fPSA（=0.012）是良性前列腺增生体积增大的危险因素；ROC曲线分析显示，HDL、FPG、PSA和fPSA联合检测的AUC为0.823，优于单项检测。综上所述，HDL、FPG、PSA、fPSA与前列腺增生密切相关，联合检测对良性前列腺增生可能具有更好的预测价值。
Zotero 插件